1
|
Wang CJ, Li Z, Bai YX, Meng WY, Liu CY, Jin L, Zhang J, Jiao MY, Jin L. Vitamin D nutritional status in early pregnancy and its relationship with periconceptional multiple micronutrients supplementation. Asia Pac J Clin Nutr 2024; 33:47-55. [PMID: 38494687 DOI: 10.6133/apjcn.202403_33(1).0006] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 03/19/2024]
Abstract
BACKGROUND AND OBJECTIVES To assess the vitamin D nutritional status (VDN) of pregnant women in early pregnancy and investigate the effects of periconceptional supplementation with multiple micronutrients (MMs) on this status. METHODS AND STUDY DESIGN Data were taken from the Pregnancy Health Care System and Hospital Information System in 2018 in Beijing. Vitamin D nutritional status in early pregnancy was evaluated among 4,978 pregnant women, and 4,540 women who took folic acid only (FA) or multiple mi-cronutrients supplements (MM) during the periconceptional period, were include to estimate the associations between periconceptional supplementation with MM and prevalence of vitamin D deficiency or insufficiency with logistic regression model. RESULTS The mean early-pregnancy vitamin D concentration was 18.6 (±7.5) ng/mL, and the rates of deficiency and insufficiency were 31.6% and 60.5%, respectively. Compared to the FA group, the adjusted odds ratio (aOR, 95%confidence interval, CI) for insufficiency or deficiency of the MM group were 0.25(0.18-0.34), and the aOR (95%CI) for deficiency of the MM group were 0.17 (0.12-0.23). Women who took MMs for a longer period of time, at higher frequencies, and with higher compliance scores had lower rates of deficiency and insufficiency. In winter, spring, and autumn, taking MMs could reduce deficiency by about 70%; in summer, there was little effect. CONCLUSIONS Among women in Beijing, serum concentrations of vitamin D in early pregnancy are relatively low, and the rates of deficiency and insufficiency are high. Taking MMs during the periconceptional period could improve this situation.
Collapse
Affiliation(s)
- Chun-Jing Wang
- Tongzhou Maternal & Child Health Hospital of Beijing, Beijing, China
| | - Zhao Li
- Institute of Reproductive and Child Health, Peking University/National Health Commission Key Laboratory of Reproductive Health, Beijing, China
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing, China
| | - Yin-Xiao Bai
- Institute of Reproductive and Child Health, Peking University/National Health Commission Key Laboratory of Reproductive Health, Beijing, China
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing, China
| | - Wen-Ying Meng
- Tongzhou Maternal & Child Health Hospital of Beijing, Beijing, China
| | - Chun-Yi Liu
- Institute of Reproductive and Child Health, Peking University/National Health Commission Key Laboratory of Reproductive Health, Beijing, China
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing, China
| | - Lei Jin
- Tongzhou Maternal & Child Health Hospital of Beijing, Beijing, China
| | - Jie Zhang
- Institute of Reproductive and Child Health, Peking University/National Health Commission Key Laboratory of Reproductive Health, Beijing, China
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing, China
| | - Ming-Yuan Jiao
- Tongzhou Maternal & Child Health Hospital of Beijing, Beijing, China
| | - Lei Jin
- Institute of Reproductive and Child Health, Peking University/National Health Commission Key Laboratory of Reproductive Health, Beijing, China
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing, China.
| |
Collapse
|
2
|
Bai YX, Liu CY, Zhang J, Meng WY, Jin L, Jin L. [Association between periconceptional supplementation of folic acid or multiple-micronutrients containing folic acid and preterm delivery in women]. Beijing Da Xue Xue Bao Yi Xue Ban 2023; 55:495-501. [PMID: 37291926] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Subscribe] [Scholar Register] [Indexed: 06/10/2023]
Abstract
OBJECTIVE To explore the association between periconceptional supplementation of folic acid or multiple-micronutrients containing folic acid(MMFA) and risk of preterm delivery in women with natural conception, singleton pregnancy and vaginal delivery. METHODS A retrospective cohort study was performed based on the prenatal health care system and hospital information system of Tongzhou Maternal and Child Health Hospital of Beijing and the women who had their prenatal care in the hospital from January 2015 to December 2018 were included. The information of 16 332 women who conceived naturally, had a singleton pregnancy, and delivered vaginally was collected. Compliance scores were constructed based on the time of initiation and the frequency of taking nutritional supplements. The association between maternal periconceptional micronutrient supplementation, including pure folic acid (FA) pills or MMFA and the rate of preterm delivery was evaluated using Logistic regression models. RESULTS The preterm delivery rate (gestational week < 37 weeks) of the study population was 3.8%, and the mean (standard deviation) of gestational age was (38.98±1.37) weeks. A total of 6 174 (37.8%) women took FA during the periconceptional period, 8 646 (52.9%) women took MMFA, and 1 512 (9.3%) women did not take any nutritional supplements. The association between periconceptional supplementation of FA or MMFA and risk of preterm delivery in women was not statistically significant [adjusted odds ratio (aOR)=1.01, 95%CI: 0.74-1.37]. The associations with preterm birth were not statistically significant in further analysis by the type of nutritional supplements, time of initiation, and the frequency of supplementation. In addition, the association between the compliance score of taking supplements and the rate of preterm delivery was not statistically significant, either. CONCLUSION This study did not find an association between the risk of preterm delivery and the use of FA or MMFA during the periconcep-tional period in women with natural conception, singleton pregnancy, and vaginal delivery. In the future, multicenter studies with large-scale prospective cohort or population-based randomized controlled trials are warranted to confirm the association between taking FA or MMFA during the periconceptional period and preterm delivery among women.
Collapse
Affiliation(s)
- Y X Bai
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
- Institute of Reproductive and Child Health, Peking University, Beijing 100191, China
- National Health Commission Key Laboratory of Reproductive Health, Beijing 100191, China
| | - C Y Liu
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
- Institute of Reproductive and Child Health, Peking University, Beijing 100191, China
- National Health Commission Key Laboratory of Reproductive Health, Beijing 100191, China
| | - J Zhang
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
- Institute of Reproductive and Child Health, Peking University, Beijing 100191, China
- National Health Commission Key Laboratory of Reproductive Health, Beijing 100191, China
| | - W Y Meng
- Department of Obstetrics, Tongzhou Maternal and Child Health Hospital of Beijing, Beijing 101100, China
| | - L Jin
- Department of Maternal Health Care, Tongzhou Maternal and Child Health Hospital of Beijing, Beijing 101100, China
| | - L Jin
- Department of Epidemiology and Biostatistics, Peking University School of Public Health, Beijing 100191, China
- Institute of Reproductive and Child Health, Peking University, Beijing 100191, China
- National Health Commission Key Laboratory of Reproductive Health, Beijing 100191, China
| |
Collapse
|
3
|
Wei YM, Liu XY, Shou C, Liu XH, Meng WY, Wang ZL, Wang YF, Wang YQ, Cai ZY, Shang LX, Sun Y, Yang HX. Value of fasting plasma glucose to screen gestational diabetes mellitus before the 24th gestational week in women with different pre-pregnancy body mass index. Chin Med J (Engl) 2019; 132:883-888. [PMID: 30958429 PMCID: PMC6595770 DOI: 10.1097/cm9.0000000000000158] [Citation(s) in RCA: 5] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2018] [Indexed: 01/19/2023] Open
Abstract
BACKGROUND Gestational diabetes mellitus (GDM) is usually diagnosed between 24th and 28th gestational week using the 75-g oral glucose tolerance test (OGTT). It is difficult to predict GDM before 24th gestational week because fast plasma glucose (FPG) decreases as the gestational age increases. It is controversial that if FPG ≥5.1 mmol/L before 24th gestational week should be intervened or not. The aim of this study was to evaluate the value of FPG to screen GDM before 24th gestational week in women with different pre-pregnancy body mass index (BMI). METHODS This was a multi-region retrospective cohort study in China. Women who had a singleton live birth between June 20, 2013 and November 30, 2014, resided in Beijing, Guangzhou and Chengdu, and received prenatal care in 21 selected hospitals, were included in this study. Pre-pregnancy BMI, FPG before the 24th gestational week, and one-step GDM screening with 75 g-OGTT at the 24th to 28th gestational weeks were extracted from medical charts and analyzed. The pregnant women were classified into four groups based on pre-pregnancy BMI: Group A (underweight, BMI < 18.5 kg/m), Group B (normal, BMI 18.5-23.9 kg/m), Group C (overweight, BMI 24.0-27.9 kg/m) and Group D (obesity, BMI ≥28.0 kg/m). The trend of FPG before 24th week of gestation was described, and the sensitivity and specificity of using FPG before the 24th gestational week to diagnose GDM among different pre-pregnancy BMI groups were reported. Differences in the means between groups were evaluated using independent sample t-test and analysis of variance. Pearson Chi-square test was used for categorical variables. RESULTS The prevalence of GDM was 20.0% (6806/34,087) in the study population. FPG decreased gradually as the gestational age increased in all pre-pregnancy BMI groups until the 19th gestational week. FPG was higher in women with higher pre-pregnancy BMI. FPG before the 24th gestational week and pre-pregnancy BMI could be used to predict GDM. The incidence of GDM in women with FPG ≥5.10 mmol/L in the 19th to 24th gestational weeks and pre-pregnancy overweight or obesity was significantly higher than that in women with FPG ≥5.10 mmol/L and pre-pregnancy BMI <24.0 kg/m (78.5% [62/79] vs. 52.9% [64/121], χ = 13.425, P < 0.001). CONCLUSIONS FPG decreased gradually as the gestational age increased in all pre-pregnancy BMI groups until the 19th gestational week. Pre-pregnancy overweight or obesity was associated with an increased FPG value before the 24th gestational week. FPG ≥5.10 mmol/L between 19 and 24 gestational weeks should be treated as GDM in women with pre-pregnancy overweight and obesity.
Collapse
Affiliation(s)
- Yu-Mei Wei
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| | - Xin-Yue Liu
- Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, FL 32611, USA
| | - Chong Shou
- Hallmark Health System, Medford, MA 02155, USA
| | - Xing-Hui Liu
- Department of Obstetrics and Gynecology, West China Second University Hospital, Chengdu, Sichuan 610041, China
| | - Wen-Ying Meng
- Department of Obstetrics and Gynecology, Tongzhou Maternal and Child Health Hospital of Beijing, Beijing 101101, China
| | - Zi-Lian Wang
- Department of Obstetrics and Gynecology, First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510080, China
| | - Yun-Feng Wang
- Department of Obstetrics and Gynecology, Beijing Miyun Hospital, Beijing 101500, China
| | - Yong-Qing Wang
- Department of Obstetrics and Gynecology, Peking University Third Hospital, Beijing 100191, China
| | - Zhen-Yu Cai
- Department of Obstetrics and Gynecology, Center Hospital of Aviation Industry, Beijing 100012, China
| | - Li-Xin Shang
- Department of Obstetrics and Gynecology, General Hospital of Beijing Military Region, Beijing 100700, China
| | - Ying Sun
- Department of Obstetrics and Gynecology, Navy General Hospital, Beijing 100000, China
| | - Hui-Xia Yang
- Department of Obstetrics and Gynecology, Peking University First Hospital, Beijing 100034, China
| |
Collapse
|
4
|
Wu Q, Meng WY, Jie Y, Zhao H. LncRNA MALAT1 induces colon cancer development by regulating miR-129-5p/HMGB1 axis. J Cell Physiol 2018; 233:6750-6757. [PMID: 29226325 DOI: 10.1002/jcp.26383] [Citation(s) in RCA: 115] [Impact Index Per Article: 19.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/10/2017] [Accepted: 12/04/2017] [Indexed: 01/08/2023]
Abstract
Recent studies have exhibited significant roles of lncRNAs in various tumors' development, including colon cancer. Our study focused on the biological roles of lncRNA MALAT1 in colon cancer. In our study, it was demonstrated that MALAT1 was upregulated in human colon cancer cell lines including Lovo, HCT116, SW480, and HT29 cells compared to the normal human intestinal epithelial HIEC cells. Moreover, we observed that miR-129-5p was downregulated in colon cancer cells with a significant increase of HMGB1 expression. Inhibition of MALAT1 can inhibit the proliferation of colon cancer SW480 and HCT116 cells and next, bioinformatics analysis was used to predict the target microRNA of MALAT1. miR-129-5p was identified and confirmed as a direct regulator of MALAT1 and it was shown that miR-129-5p mimics were able to restrain the progression of colon cancer cells. In addition, high motility group box protein 1 (HMGB1), was predicted as a mRNA target of miR-129-5p. Furthermore, we found that MALAT1 exerted its biological functions through regulating HMGB1 by sponging miR-129-5p in vitro. Silencing MALAT1 greatly inhibited HMGB1 expression which can be reversed by miR-129-5p inhibitors. It was indicated in our investigation that MALAT1 may serve as a competing endogenous lncRNA (ceRNA) to mediate HMGB1 by sponging miR-129-5p in colon cancer. Taken together, our results indicated that MALAT1/miR-129-5p/HMGB1 axis could be provided as an important prognostic biomarker in colon cancer development.
Collapse
Affiliation(s)
- Qiong Wu
- Department of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Wen-Ying Meng
- Department of Gastroenterology, Shanghai Tongren Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
| | - Ying Jie
- Department of Clinical Research Center, People's Hospital of Xuyi, Jiangsu Province, China
| | - Haijian Zhao
- Division of Pediatric Surgery, Department of General Surgery, Huai'an Second People's Hospital and The Affiliated Huai'an Hospital of Xuzhou Medical University, Jiangsu, China
| |
Collapse
|
5
|
Cai Q, Meng WY, Zhang HY, Wang HL, Qi H, Zhou YM. [Immediate restoration of dental implant using computer-assisted navigation in the esthetic zone: a case report]. Zhonghua Kou Qiang Yi Xue Za Zhi 2017; 52:57-58. [PMID: 28072998 DOI: 10.3760/cma.j.issn.1002-0098.2017.01.013] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Subscribe] [Scholar Register] [Indexed: 06/06/2023]
Affiliation(s)
- Q Cai
- Department of Dental Implantology, School of Stomatology, Jilin University, Changchun 130021, China
| | - W Y Meng
- Department of Dental Implantology, School of Stomatology, Jilin University, Changchun 130021, China
| | - H Y Zhang
- Department of Dental Implantology, School of Stomatology, Jilin University, Changchun 130021, China
| | - H L Wang
- Department of Dental Implantology, School of Stomatology, Jilin University, Changchun 130021, China
| | - H Qi
- Department of Dental Implantology, School of Stomatology, Jilin University, Changchun 130021, China
| | - Y M Zhou
- Department of Dental Implantology, School of Stomatology, Jilin University, Changchun 130021, China
| |
Collapse
|
6
|
Shi M, Wei J, Meng WY, Wang N, Wang T, Wang YG. Effects of phased joint intervention on Rho/ROCK expression levels in patients with portal hypertension. Exp Ther Med 2016; 12:1618-1624. [PMID: 27602079 DOI: 10.3892/etm.2016.3454] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/29/2015] [Accepted: 05/11/2016] [Indexed: 11/06/2022] Open
Abstract
The current study investigated the effects of phased joint intervention on clinical efficacy and Rho/Rho-associated coil protein kinase (ROCK) expression in patients with portal hypertension complicated by esophageal variceal bleeding (EVB) and hypersplenism. Patients with portal hypertension (n=53) caused by liver cirrhosis complicated by EVB and hypersplenism treated with phased joint intervention were assessed, and portal hemodynamics, blood, liver function, complications, and rebleeding incidence were analyzed. Reverse transcription-quantitative polymerase chain reaction was used to measure Rho, ROCK1 and ROCK2 mRNA expression levels in peripheral blood mononuclear cells prior to and following phased joint intervention, and western blotting was employed to determine the protein expression levels of Rho, ROCK1, ROCK2, phosphorylated (p) myosin phosphatase target subunit 1 (MYPT1) and total-MYPT1. All patients underwent an emergency assessment of hemostasis with a 100% success rate. Varicose veins were alleviated, and portal hemodynamics and liver function improved following intervention. Furthermore, preoperative and postoperative expression levels of Rho, ROCK1 and ROCK2 mRNA were higher compared with the control group. Notably, the mRNA expression levels of Rho, ROCK1 and ROCK2 in the postoperative group were significantly lower when compared with the preoperative group. Protein expression levels of Rho, ROCK1, ROCK2 and pMYPT1 in the postoperative group were lower, as compared with the preoperative group. Concentration levels of transforming growth factor-β1, connective tissue growth factor and platelet-derived growth factor in peripheral blood were significantly reduced following phased joint intervention. Therefore, the present findings demonstrated that phased joint intervention is able to effectively treat EVB and hypersplenism, and improve liver function. The efficacy of phased joint intervention may be associated with its role in the regulation of the Rho-ROCK signaling pathway.
Collapse
Affiliation(s)
- Min Shi
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Jue Wei
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Wen-Ying Meng
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Na Wang
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Ting Wang
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Yu-Gang Wang
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| |
Collapse
|
7
|
Zhu YC, Yang HX, Wei YM, Zhu WW, Meng WY, Wang YQ, Shang LX, Cai ZY, Ji LP, Wang YF, Sun Y, Liu JX, Wei L, Sun YF, Zhang XY, Luo TX, Chen HX, Yu LJ. Analysis of correlation factors and pregnancy outcomes of hypertensive disorders of pregnancy - a secondary analysis of a random sampling in Beijing, China. J Matern Fetal Neonatal Med 2016; 30:751-754. [PMID: 27145691 DOI: 10.1080/14767058.2016.1186161] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/21/2023]
Abstract
OBJECTIVE We aimed to assess the prevalence and risk factors for hypertensive disorders and to study the main pregnancy outcomes in the Beijing area of China. STUDY DESIGN This study randomly sampled 15 hospitals in Beijing from Jun 2013 to Nov 2013 and evaluated 15 194 deliveries. Logistic regression analysis was used to study the association between risk factors and hypertensive disorders. Pregnancy outcomes included preterm birth, cesarean delivery and small for gestational age (SGA). RESULTS The prevalence of hypertensive disorders, preeclampsia (PE) and severe PE was 4.4, 2.7 and 1.8%, respectively. The risk factors for hypertensive disorders and severe PE were maternal body mass index before pregnancy, gestational weight gain (GWG), gestational diabetes and pre-gestational diabetes, and third trimester cholesterol (CHOL) levels. First trimester high-density lipoprotein was a protective factor for severe PE. The incidence of hypertensive disorders increased with maternal age. Preterm delivery, cesarean delivery and small infant size for gestational age were more prevalent in the severe PE group compared with the non-hypertensive group. CONCLUSIONS In the Beijing area of China, maternal body mass index before pregnancy, GWG, maternal complications of gestational diabetes and pre-gestational diabetes, and third trimester CHOL levels are risk factors for both hypertensive disorders of pregnancy and severe PE. First trimester high-density lipoprotein is a protective factor for severe PE. Severe preeclampsia leads to a higher incidence of preterm delivery, cesarean delivery and SGA infants.
Collapse
Affiliation(s)
- Yu-Chun Zhu
- a Department of Obstetrics and Gynecology , Peking University First Hospital , Beijing , PR China
| | - Hui-Xia Yang
- a Department of Obstetrics and Gynecology , Peking University First Hospital , Beijing , PR China
| | - Yu-Mei Wei
- a Department of Obstetrics and Gynecology , Peking University First Hospital , Beijing , PR China
| | - Wei-Wei Zhu
- a Department of Obstetrics and Gynecology , Peking University First Hospital , Beijing , PR China
| | - Wen-Ying Meng
- b Tongzhou Maternal and Child Health Hospital of Beijing , Beijing , PR China
| | - Yong-Qing Wang
- c Department of Obstetrics and Gynecology , Peking University Third Hospital , Beijing , PR China
| | - Li-Xin Shang
- d Department of Obstetrics and Gynecology , General Hospital of Beijing Military Region , Beijing , PR China
| | - Zhen-Yu Cai
- e Center Hospital of Aviation Industry , Beijing , PR China
| | - Li-Ping Ji
- f Pinggu Maternal and Child Health Hospital of Beijing , Beijing , PR China
| | - Yun-Feng Wang
- g Beijing Hospital of Miyun City , Beijing , PR China
| | - Ying Sun
- h Navy General Hospital , Beijing , PR China
| | - Jia-Xiu Liu
- i Beijing Daxing District Hongxing Hospital , Beijing , PR China
| | - Li Wei
- j Beijing Chui Yang Liu Hospital , Beijing , PR China
| | - Yu-Feng Sun
- k Peking University Shougang Hospital , Beijing , PR China
| | - Xue-Ying Zhang
- l Combined with Traditional Chinese and Western Medicine Hospital of Beijing City , Beijing , PR China
| | | | - Hai-Xia Chen
- n Beijing Changping Hospital of Traditional Chinese Medicine , Beijing , PR China , and
| | - Li-Jun Yu
- o General Hospital of Jingmei Group , Beijing , PR China
| |
Collapse
|
8
|
Wei YM, Yang HX, Zhu WW, Liu XY, Meng WY, Wang YQ, Shang LX, Cai ZY, Ji LP, Wang YF, Sun Y, Liu JX, Wei L, Sun YF, Zhang XY, Luo TX, Chen HX, Yu LJ. Risk of adverse pregnancy outcomes stratified for pre-pregnancy body mass index. J Matern Fetal Neonatal Med 2015; 29:2205-9. [PMID: 26427602 DOI: 10.3109/14767058.2015.1081167] [Citation(s) in RCA: 50] [Impact Index Per Article: 5.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/05/2023]
Affiliation(s)
- Yu-Mei Wei
- Peking University First Hospital, Beijing, China
| | - Hui-Xia Yang
- Peking University First Hospital, Beijing, China
| | - Wei-Wei Zhu
- Peking University First Hospital, Beijing, China
| | - Xin-Yue Liu
- Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, FL, USA
| | - Wen-Ying Meng
- Tongzhou Maternal and Child Health Hospital of Beijing, Beijing, China
| | | | - Li-Xin Shang
- General Hospital of Beijing Military Region, Beijing, China
| | - Zhen-Yu Cai
- Center Hospital of Aviation Industry, Beijing, China
| | - Li-Ping Ji
- Pinggu Maternal and Child Health Hospital of Beijing, Beijing, China
| | | | - Ying Sun
- Navy General Hospital, Beijing, China
| | - Jia-Xiu Liu
- Beijing Daxing District Hongxing Hospital, Beijing, China
| | - Li Wei
- Beijing Chui Yang Liu Hospital, Beijing, China
| | - Yu-Feng Sun
- Peking University Shougang Hospital, Beijing, China
| | - Xue-Ying Zhang
- Combined with Traditional Chinese and Western Medicine Hospital of Beijing City, Beijing, China
| | | | - Hai-Xia Chen
- Beijing Changping Hospital of Traditional Chinese Medicine, Beijing, China, and
| | - Li-Jun Yu
- General Hospital of Jingmei Group, Beijing, China
| |
Collapse
|
9
|
Wang YG, Xu L, Wang T, Wei J, Meng WY, Wang N, Shi M. Givinostat inhibition of hepatic stellate cell proliferation and protein acetylation. World J Gastroenterol 2015; 21:8326-8339. [PMID: 26217084 PMCID: PMC4507102 DOI: 10.3748/wjg.v21.i27.8326] [Citation(s) in RCA: 14] [Impact Index Per Article: 1.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Download PDF] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/19/2015] [Revised: 03/02/2015] [Accepted: 05/21/2015] [Indexed: 02/06/2023] Open
Abstract
AIM: To explore the effect of the histone deacetylase inhibitor givinostat on proteins related to regulation of hepatic stellate cell proliferation.
METHODS: The cell counting kit-8 assay and flow cytometry were used to observe changes in proliferation, apoptosis, and cell cycle in hepatic stellate cells treated with givinostat. Western blot was used to observe expression changes in p21, p57, CDK4, CDK6, cyclinD1, caspase-3, and caspase-9 in hepatic stellate cells exposed to givinostat. The scratch assay was used to analyze the effect of givinostat on cell migration. Effects of givinostat on the reactive oxygen species profile, mitochondrial membrane potential, and mitochondrial permeability transition pore opening in JS-1 cells were observed by laser confocal microscopy.
RESULTS: Givinostat significantly inhibited JS-1 cell proliferation and promoted cell apoptosis, leading to cell cycle arrest in G0/G1 phases. Treatment with givinostat downregulated protein expression of CDK4, CDK6, and cyclin D1, whereas expression of p21 and p57 was significantly increased. The givinostat-induced apoptosis of hepatic stellate cells was mainly mediated through p38 and extracellular signal-regulated kinase 1/2. Givinostat treatment increased intracellular reactive oxygen species production, decreased mitochondrial membrane potential, and promoted mitochondrial permeability transition pore opening. Acetylation of superoxide dismutase (acetyl K68) and nuclear factor-κB p65 (acetyl K310) was upregulated, while there was no change in protein expression. Moreover, the notable beneficial effect of givinostat on liver fibrosis was also confirmed in the mouse models.
CONCLUSION: Givinostat has antifibrotic activities via regulating the acetylation of nuclear factor-κB and superoxide dismutase 2, thus inhibiting hepatic stellate cell proliferation and inducing apoptosis.
Collapse
|
10
|
Xu L, Wang T, Meng WY, Wei J, Ma JL, Shi M, Wang YG. Salinomycin inhibits hepatocellular carcinoma cell invasion and migration through JNK/JunD pathway-mediated MMP9 expression. Oncol Rep 2014; 33:1057-63. [PMID: 25522777 PMCID: PMC4324482 DOI: 10.3892/or.2014.3680] [Citation(s) in RCA: 13] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/08/2014] [Accepted: 11/28/2014] [Indexed: 12/27/2022] Open
Abstract
The antibiotic salinomycin (Salin) was recently identified as an antitumor drug for the treatment of several types of solid tumors. However, the effects of Salin on the migratory and invasive properties of hepatocellular carcinoma (HCC) cells are unclear. The present study aimed to determine the antitumor efficacy and mechanism of Salin in HCC cells. Human HCC cells (HCCLM3) treated with Salin showed a concentration-dependent reduction in cell migration and invasion, and this was associated with reduced MMP9 expression. The MMP9 promoter and enhancer in a luciferase reporter assay revealed that Salin can regulate MMP9 expression through an activator protein (AP-1) site within the MMP9 enhancer. JunD, one of the AP-1 components, was significantly decreased by Salin in a concentration- and time-dependent manner. Salin was able to induce c-Jun NH2-kinase (JNK) phosphorylation and to block both JunD and MMP9 expression. Our results showed that JNK phosphorylation and JunD may be involved in the Salin-regulated MMP9 signaling pathway in HCCLM3 cells and may mediate HCC cell biological characteristics. Our studies provide new insight into the antitumor effects of Salin.
Collapse
Affiliation(s)
- Ling Xu
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Ting Wang
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Wen-Ying Meng
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Jue Wei
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Jia-Li Ma
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Min Shi
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| | - Yu-Gang Wang
- Department of Gastroenterology, Shanghai Tongren Hospital, Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai 200336, P.R. China
| |
Collapse
|